Episode 24: Samsara Biocapital's Srini Akkaraju
BioVenture VoiCes with Chris Garabedian
00:00
Genentech's focus and lessons in BD
Srini discusses Genentech's evolving therapeutic focus, deals like Rituxan, and learning drug-development risk lenses.
Play episode from 14:56
Transcript
